Summary To understand genetic events which play a role in the development and/or progression of human endometrial cancer, we studied allelotypes on all autosomal chromosomes, as well as chromosome X, with 42 microsatellite markers and 56 endometrial cancers. The most frequent loss of heterozygosity (LOH) was observed on the long arm of chromosome 10 (14 of 30, 47%), which was commonly detected in grade 1 cancer.
Endometrial cancer is one of the most common female pelvic malignant diseases in the world. Approximately 33 000 new cases are diagnosed annually in the United States (Parkin et al., 1988) . The incidence in Japan is 4.01 cases per 100 -000 females in 1989 (Fujimoto et al., 1993) . Moreover, the rate of endometrial cancer is increasing yearly and has doubled in Japan in the last 10 years (Fujimoto et al., 1993) . Although recent advances in medical science have revealed molecular mechanisms in some cancers, such as colorectal cancer (Fearon and Vogelstein, 1990) , only a limited amount of information about the molecular mechanism in endometrial carcinogenesis has been reported. In previous studies, p53 and ras appeared to be involved in the development of endometrial cancer, but the incidence of alterations in these two genes was not high; the reported mutation frequency of p53 is 10-20% (Okamoto et al., 1991; Risinger et al., 1992) and activation of K-ras is 10-30% (Enomoto et al., 1990 (Enomoto et al., , 1991 Ignar-Trowbridge et al., 1992) . Microsatellite instability, one of the major mechanisms in cancer susceptibility, has been reported in about 20% of sporadic endometrial cancer (Han et al., 1993; Risinger et al., 1993; Duggan et al., 1994; Burks et al., 1994; Peiffer et al., 1995) , and a mutation of hMLHI was found in a sporadic case of endometrial cancer (Fukushige et al., 1996) . Thus, defects in DNA mismatch repair genes have been implicated in some fraction of endometrial cancers. However, it is not clear whether defects in DNA mismatch repair genes result in genetic alteration in oncogenes and/or tumour-suppressor genes that are associated with endometrial carcinogenesis. Moreover, molecular mechanisms, including genes, that play an important role in endometrial carcinogenesis are still an open question. As the first step in obtaining a better understanding of molecular mechanisms of endometrial carcinogenesis, we analysed allelic losses to search for loci that may harbour putative tumoursuppressor genes. Although several investigators have reported frequent LOH on chromosome arms 3p, 10q, 17p and 18q (Okamoto et al., 1991; Jones et al., 1994; Fujino et al., 1994; Peiffer et al., 1995) , investigations are not yet complete. In the present study, we analysed allelotypes in 56 endometrial cancers using 42 microsatellite markers that spanned all chromosome arms and identified frequent allelic losses on chromosome arms 10q and 16q; 10q showed a strikingly high incidence of deletion. For these reasons, we constructed a detailed deletion map of the long arm of chromosome 10 in endometrial cancers. Here, we report the identification of two commonly deleted regions in chromosome arm 1Oq.
Materials and methods
Tissue samples and DNA extraction Since contamination of normal cells in cancerous tissue would mask allelic loss, which would lead to erroneous interpretation of LOH studies, we examined 71 endometrial cancer tissues histopathologically and selected 56 tumours in which contamination by normal cells was less than 50% of the total. All the surgically removed samples analysed in the present study were obtained from Japanese patients in Tohoku University Hospital and its related hospitals. Tissues were fixed in formalin and embedded in paraffin. DNAs were extracted according to methods described previously (Goelz et al., 1985; Yanagisawa et al., 1991 (Okamoto et al., 1991; Jones et al., 1994; Fujino et al., 1994; Peiffer et al., 1995) . Although we did not find frequent LOH on 3p, 17p or 18q, our data confirmed previous reports of frequent LOH in lOq23-q26 (Jones et al., 1994; Peiffer et al., 1995) . In the present study, we were able to narrow this down and find two commonly deleted regions of approximately 8 cM and 12 cM in lOq25-q26. Recently, MXII was mapped in lOq24-q25 (Wechsler et al., 1994) , which would act as a negative regulator of c-myc (Zervos et al., 1993) . Peiffer et al. (1995) suggested the possibility of this gene as the tumour-suppressor gene for endometrial cancer. However, MXII was reported to be localised in two overlapping YAC clones at D1OS597 (Gray et al., 1995) . Hence, we conclude that MXII is outside of the In the present study, we detected frequent microsatellite instabilities (24 of 56, 43%), agreeing with previous reports (Han et al., 1993; Risinger et al., 1993; Duggan et al., 1994; Burks et al., 1994; Peiffer et al., 1995) . In 12 cases that showed RERs at more than half of the microsatellite loci, one was a multiple primary cancer patient who had a somatic mutation in hMLHJ in her endometrial cancer; no other mutation in either hMLHI or hMSH2 was detected 
